Day: November 23, 2022

SHANGHAI, China, Nov. 23, 2022 (GLOBE NEWSWIRE) — 360 DigiTech, Inc. (NASDAQ: QFIN) (“360 DigiTech” or the “Company”), a Credit-Tech platform in China, today announced the pricing of its global offering (the “Global Offering”) of 5,540,000 Class A ordinary shares of the Company (the “Offer Shares”). The Global Offering comprises a Hong Kong public offering (the “Hong Kong Public Offering”) and an international offering (the “International Offering”). The final offer price for both the International Offering and the Hong Kong Public Offering (the “Offer Price”) has been set as HK$50.03 per Offer Share. Based on the ratio of two Class A ordinary shares per Nasdaq-listed American depositary shares (the “ADSs”), the Offer Price translates to approximately US$12.75 per ADS based on an exchange rate of HK$7.8499 to US$1.00. Subject to...

VANCOUVER, British Columbia, Nov. 23, 2022 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) announces that, subsequent to the LOI, Sirona and Wanbang Biopharmaceuticals (“Wanbang”) have signed an expanded, international partnership agreement to collaborate on licencing Sirona’s SGLT2 inhibitor, TFC-039, as a pharmaceutical treatment in both animal and human health. The agreement adds human health to the partnership as a result of new licencing opportunities currently in due diligence. Wanbang (a wholly owned subsidiary of Shanghai Fosun Pharmaceutical) and Sirona initially signed a licensing agreement for TFC-039, whereby Wanbang obtained the rights to develop the compound as a diabetes treatment in China and Sirona retained the global rights. Sirona has since been in discussions with animal...

GLYFADA, Greece, Nov. 23, 2022 (GLOBE NEWSWIRE) — Globus Maritime Limited (“Globus” or the “Company”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that it will release financial results for the three- and nine-months period ended September 30, 2022, after the market closes in New York on Monday, November 28, 2022. About Globus Maritime Limited Globus is an integrated dry bulk shipping company that provides marine transportation services worldwide and presently owns, operates, and manages a fleet of nine dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina and other dry bulk cargoes internationally. Globus’ subsidiaries own and operate nine vessels with a total carrying capacity of 626,257DWT and a weighted average age of 11.1 years as of November 28, 2022. Safe Harbor Statement This...

MONTREAL, Nov. 23, 2022 (GLOBE NEWSWIRE) — Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) has acquired by map staking a 29-cell property comprising approximately 1,490 hectares east of the Adina lithium showing, in Jamesie (QC). The Dalmas SM project is located in a favorable geological environment for strategic minerals such as lithium, nickel, copper, chromium, and cobalt. We find the presence of peridotite, pyroxenite as well as a pegmatitic granite containing beryl. According to data from the Quebec Ministry of Energy and Natural Resources, this property contains several geochemical showings of nickel, copper, and lithium. An exploration program will be necessary to assess its full potential during 2023. “The current geopolitical context favors lithium projects in Quebec, and we intend to use our exploration...

VANCOUVER, Nov. 23, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (CSE: CMND), (FSE: CWY) (“Clearmind” or the “Company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced the initiation of clinical batches of production of its novel psychedelic-derived drug candidate, the MEAI- based molecule- CMND-100. The produced batches will be used in the Company’s upcoming first in human (FIH) clinical trial evaluating the proprietary drug candidate compound CMND-100 for the treatment of Alcohol Use Disorder (AUD). Following MEAI’s synthesis development process, the compound is being produced under GMP (Good Manufacturing Process) conditions to comply with FDA requirements. The clinical batches...

Summary The market for the company’s vessels in the third quarter has been better in all segments than the corresponding period in 2021. Revenues and profit are significantly affected by the sale of vessels. Agreement with lenders entered into in 2020 clarifies the company’s obligations towards the lenders for the period until 2024. Five vessels that have been in lay-up, of which 3 AHTS and 2 PSV, have been sold. Of these, 3 vessels were delivered to new owners in the second quarter, one vessel was delivered in the third quarter and one vessel was delivered in October. Another vessel has been agreed to be sold and is expected to be delivered to the new owner around the turn of the year. Havila Shipping ASA achieved an operating income before depreciation of NOK 105.2 million in Q3 2022, compared with NOK 53.7 million in Q3 2021. Total...